Brandywine Oak Private Wealth’s Quest Diagnostics DGX Stock Holding History

Brandywine Oak Private Wealth’s Portfolio DGX Stock Details DGX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-1,653	Closed	-$202K	–	258
2022 Q3	$202K	Sell	1,653 -47	-3%	-$6.19K	0.03%	289
2022 Q2	$226K	Sell	1,700 -82	-5%	-$11.2K	0.03%	290
2022 Q1	$243K	Buy	1,782 +236	+15%	+$32.9K	0.03%	309
2021 Q4	$293K	Sell	1,546 -446	-22%	-$67.9K	0.03%	252
2021 Q3	$287K	Hold	1,992	–	–	0.03%	263
2021 Q2	$262K	Buy	+1,992	New	+$261K	0.03%	267
2021 Q1	–	Sell	-1,721	Closed	-$205K	–	277
2020 Q4	$205K	Buy	+1,721	New	+$210K	0.03%	261

Other funds holding DGX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

DSA

Davis Selected Advisers Tucson, Arizona $21.8B AUM 23.45% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Brandywine Oak Private Wealth's DGX Position: Q4 2022 in Review

Brandywine Oak Private Wealth sold out of Quest Diagnostics (DGX) in Q4 2022, closing a stake of 1,653 shares — an estimated $202K sold.

Brandywine Oak Private Wealth first reported a position in DGX in Q4 2020 and held it in 7 quarters. The position peaked at $293K in Q4 2021. 879 funds tracked by Wall St. Rank hold DGX as of Q4 2022.

Brandywine Oak Private Wealth reported no remaining Quest Diagnostics position as of Q4 2022 after selling out during the quarter.
Brandywine Oak Private Wealth sold 1,653 Quest Diagnostics shares in Q4 2022, an estimated $202K.
Brandywine Oak Private Wealth first reported a position in Quest Diagnostics in Q4 2020 and held it in 7 quarters.
Brandywine Oak Private Wealth's Quest Diagnostics position peaked at $293K in Q4 2021.
879 funds tracked by Wall St. Rank held Quest Diagnostics as of Q4 2022.

Based on Brandywine Oak Private Wealth's 13F filing for Q4 2022, filed 6 Feb 2023.